absent in six out of 24 patients who presented with recurrent chest infections but who had normal serum IgG inumunoglobulin levels. Three had normal levels of IgG or IgM or both, but three had depression of serum IgM. One patient was suffering from chronic lymphatic leukaemia. Five of these patients were subsequently treated with gammaglobulin injections which resulted in a reduction in the frequency of their infections. IgG levels in three patients subsequently fell to subnormal levels, suggesting that the absence of E. coli antibody occurred before a quantitative immunoglobulin deficiency.
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About 70% of normal subjects have haeimagglutinating E. coli antibody which is destroyed by mercaptoethanol. This finding supports previous contentions (Michael and Rosen, 1963 ) that much of the serum antibody against Gram-negative organisms is of the IgM type. It is not possible, however, to make any statements about the quantity of IgG antibody present since haemagglutinating techniques favour the recognition of IgM. Nevertheless, about 30% of normal adults have haemagglutinating antibody of the 7S variety (mercaptoethanol resistan,t) . This is likely to be IgG antibody, which is in keeping with the observations of Cohen and Norins (1968) . The common occurrence of IgG antibodies to E. coli probably explains why we found no correlation between the level of serum IgM and the titre of E. coli antibody or between the titre of isohaemagglutinins and E. coli antibody in patients studied. Despite the absence of E. coli antibodies in most of the patients with hypoganmaglobulinaemia there were no cases of lower or upper urinary tract infection. It is exceptional for such patients to suffer from any infective complication of the urinary tract, and in our wider series of about 70 patients (18 females) there was only one case of recurrent cystitis and this was associated with a sterile pyuria.
It is possible that a defect in the production of E. coli antibody may be due to a specific defect in the response to polysaccharide antigens. Work with mice has shown that some of these responses are independent of thym-iic processed T cells (Baker et al., 1970 
Introduction
The linoleic acid content of serum lipids is decreased in multiple sclerosis (Baker et al., 1964; Tichy et al., 1969) . The cholesterol ester fraction shows the greatest decrease in linoleate content (Baker et al., 1965) . Moreover, the decreased linoleate fraction is not peculiar to plasma lipids but also occurs in lipids of red cells and platelets (Gul et al., 1970) . Previous work established that the fatty-acid composition of phosphatidylcholines (lecithins) from the brains of patients with multiple sclerosis differed from that of normal brain (Baker et al., 1963) . Even in non-plaque areas saturated fatty acids increased relative to unsaturated fatty acids. Several other reports have shown changes in relative proportions of saturated and unsaturated fatty acids in brains of multiple sclerosis patients (Gerstel et al., 1961; Cumings et al., 1965; Arnetoli et al., 1969; Clausen and Hanson, 1970; Gerstel et al., 1970; Alling et al., 1971) .
Previous studies compared linoleic acid composition of serum lipids in multiple sclerosis with levels in subjects with other neurological disorders and in healthy subjects (Baker et al., 1964; Belin et al., 1971) . No comparison seems to have been made with diseases which did not have a neurological basis. We considered that it was essential to examine linoleic acid levels of serum lipids in non-neurological diseases before coming to a definite conclusion about the significance of altered linoleic acid levels in multiple sclerosis.
We therefore set out to compare the levels of serum linoleic acid in multiple sclerosis with levels found in acute hospital admissions suffering from diseases which did not have a neurological basis. For the purpose of comparison patients with neurological diseases other than multiple sclerosis and healthy subjects were also studied. Preliminary reports of this work have been published (Love et al., 1972 . Some subjects selected from this study were included in a simultaneous dietary survey .
Subjects and Methods
The groups studied consisted of 47 patients with multiple sclerosis, 35 with a variety of acute non-neurological illnesses, 29 with neurological diseases other than multiple sclerosis, and 49 healthy control subjects.
MULTIPLE SCLEROSIS PATIENTS
The 47 patients with multiple sclerosis, whose ages ranged from 20 to 58 years (mean 39 years), were divided into three groups as follows: group 1 consisted of 14 patients (nine men, five women) who were seen during acute exacerbations of the disease. The incapacity of this group before the exacerbations was minimal and did not interfere with their normal daily activities. Their disability on admission to hospital was such that it was necessary to confine all patients to bed initially. Group 2 consisted of 21 cases (10 men, 11 women). This group showed progressive deterioration of the disease to the extent that it interfered with normal daily activities. The patients in this group were ambulant at the time of the investigation. Group 3 consisted of 12 cases (seven men, five women) permanently confined to bed or to a wheelchair.
Only patients whose clinical presentation was compatible with the criteria suggested by McAlpine et al. (1972) for definite cases of multiple sclerosis were included in the study.
ACUTELY ILL PATIENTS
Patients with acute non-neurological illness consisted of 15 men and 20 women. Their ages ranged from 20 to 55 years (mean 37 years). The patients were divided into those with infective and those with non-infective diseases. The group with infective diseases included 18 patients with acute respiratory infections, one with agranulocytosis with pharyngitis, and one with acute cholecystitis. The group with non-infective diseases was made up of three patients with myocardial infarction, three with severe anaemia, two with rheumatoid arthritis, two with peptic ulceration, two with carcinoma of lung, one with thyrotoxicosis, one with acute renal failure, and one with Hodgkin's disease.
NEUROLOGICAL CONTROLS
There were 12 men and 17 women with neurological diseases other than multiple sclerosis. Their ages ranged from 25 to 56 years (mean 38 years). The diseases studied in this group were as follows: acute disc lesions (six cases), epilepsy (five cases), spinal cord tumours (four cases), acute infective polyneuritis (two cases), cerebrovascular accidents (two cases), brain tumours (two cases), and ophthalmoplegic migrane, acute transverse myelitis, torsion dystonia, Parkinson's disease, motor neurone disease, spinal-cord arachnoiditis, dementia, and subacute combined degeneration of the cord (one case of each).
HEALTHY CONTROL SUBJECTS
The healthy subjects were selected from army personnel and hospital staff. The ages of the 33 men and 16 women ranged 19 from 20 to 50 years (mean 35 years). All volunteered to take part in the trial.
ANALYTICAL PROCEDURES
Blood samples were taken from all subjects after an overnight fast. The serum was separated within two hours and stored at -20°C until processed. Total lipids were extracted, hydrolysed, and the fatty-acid methyl esters prepared and analysed as described by Baker et al. (1964) . The fatty-acid methyl esters were separated by gas-liquid chromatography using a 5 ft (1-5 m) metal column (1 mm bore) packed with 15% polyethylene glycol adipate on 80-120 mesh diatomaceous celite at 190°C and a flame ionization detector in a Pye Series 104 chromatograph. The chromatograms were analysed by triangulation of the peaks and the individual fatty acids expressed as a percentage of total fatty acids. Serum cholesterol was determined by a modified Lieberman-Burchard reaction (Carr and Drekter, 1956 Mean serum cholesterol 231 ± 11 217 ± 24 275 ± 13 301 ± 27 + S.E. of Mean (mg/100 ml)
Results
The fatty-acid pattem in the various groups is shown in table 1, and the statistical relations of these patterns are summarized in table II. While we confirmed that linoleic acid levels were decreased in multiple sclerosis patients it was also apparent that a similar decrease occurred in neurological diseases other than multiple sclerosis and, even more strikingly, that the greatest decrease occurred in patients with acute illness of a nonneurological nature (P< 0-001 in all groups). While serum linoleic acid levels decreased the non-essential fatty acids oleate and palmitate showed a significant increase in all the ill patients compared with healthy controls. A decrease in stearic acid levels seemed to accompany the increase in oleic acid in each group. Similarly palmitoleic acid levels also increased as linoleic acid levels decreased. Thus it seemed that as the essential unsaturated fatty acid-linoleic acid-decreased the unsaturated fatty acid stearic acid-a precursor of oleic acid-also decreased and palmitoleic acid and its precursor palmitic acid both increased.
The ratio of unsaturated fatty acids to saturated fatty acids remained remarkably constant despite the alterations in individual fatty acids (table III) . In acute illness, however, the ratio showed a decrease.
When the multiple sclerosis patients were divided into groups according to the activity of the disease the lowest levels of linoleic acid were found in patients during acute exacerbations (group 1) and in those permanently confined to bed or wheelchair (group 3; table IV). Multiple sclerosis patients with progressive deterioration of the disease (group 2) had linoleic (Coombes et al., 1962) . The mean cholesterol level in plasma of the multiple sclerosis was lowest in group 1, was increased in group 2, and was greatest in group 3.
Thus linoleic acid levels were decreased not only in multiple sclerosis but also in other neurological disorders and even more so in acute non-neurological illnesses (P< 0-001 in all cases when compared to healthy controls). Furthermore, patients with acute illness had linoleic acid levels significantly lower than those in multiple sclerosis (P< 0-001; table II).
Within the acute-illness group there was no significant difference between linoleic acid levels of serum lipids in infective and non-infective illnesses.
Discussion
This study showed that the reduction in the levels of linoleic acid in the serum lipids was not restricted to multiple sclerosis. A highly significant reduction occurred in acute non-neurological diseases, in which the lowest levels were found. Unlike previous workers (Baker et al., 1964) we have shown a significant reduction in levels in neurological diseases other than multiple sclerosis. The lowest levels were present in acutely ill patients and in the most severely incapacitated multiple sclerosis patients, suggesting that the serum levels of linoleic acid are reduced in relation to the serverity of illness. It has previously been shown (Baker et al., 1964) that the levels fall with evidence of increased deterioration in patients with multiple sclerosis.
When one examines the fatty acid composition of serum lipids in the different groups in this study a definite pattern
emerges. An inverse relation existed between linoleic acid levels on the one hand and palmitic, oleic, and palmitoleic acid levels on the other. The sum of the unsaturated acids (oleic, linoleic, and palmitoleic) was remarkably constant in each group except that with acute illness (see table III) . Similarly, the sum of the saturated fatty acids was remarkably constant. These changes resembled those seen in essential fatty acid deficiency, where non-essential unsaturated fatty acids increase when there is a deficiency of essential fatty acids (Wiese, 1971) . Experiments in animals confirm that in linoleic acid deficiency palmitic, palmitoleic, and oleic acid synthesis is increased (Allman and Gibson, 1965; Allman et al., 1965) . These workers have also shown an increase in cholesterol esters in tissues in linoleic acid deficiency, and, conversely, it has been shown that cholesterol and saturated fatty acid feeding increase linoleic acid requirements (Aaes-Jorgensen, 1961; Holman, 1960) .
In this respect it is worth comment that we found that the lowest levels of linoleic acid were associated with the highest levels of palmitic acid, especially in patients with acute illness of a non-neurological origin. Furthermore, we have previously shown in a dietary survey that the lowest intake of linoleic acid occurred in this group . That the highest levels of cholesterol were also found in this group may be related to the observation that cholesterol accumulation is a feature of essential fatty acid deficiency (Coombes et al., 1962) . It has also been shown that tissue levels of palmitoleic and oleic acids are increased when linoleic acid is deficient in the diet (Coombes et al., 1962) .
Since our study has shown that alterations in the levels of linoleic acid occur in a wide variety of illnesses possibly a similar basis for the reduced levels may be present in all of the diseases studied. It has already been shown that linoleic acid absorption is normal in multiple sclerosis patients (Belin et al., 1971) and it is unlikely that any defect of absorption occurred in any of the diseases included in this study. In a simultaneous dietary survey a significant reduction in the intake of linoleic acid was shown only in patients with acute non-neurological illness . It is therefore possible that the changes that occurred in the fatty-acid pattern in illness were related to some disturbance of fatty-acid metabolism that occurred after the absorption of linoleic acid. It has previously been shown that low serum linoleic acid levels in cholesterol esters occur in patients with carcinoma of the liver (Zoilner and Wolfram, 1961) , among poor East Africans (Scott, 1963) , among chronic alcoholics (Alling et al., 1967) , and after dissection of the ileum (Collins et al., 1971) . Linoleic acid content of serum free fatty acids, cholesterol esters, phospholipids, and triglycerides is reduced after myocardial infarction (Kirkeby, 1972 a; Kirkeby et al., 1972) . Similar findings have been described after injection of growth hormone (Jurand and Oliver, 1970 a) , after administration of thyroxine (Kirkeby, 1972 b) , in hyperthyroidism (Kirkeby, 1972 c) , and in hypothyroidism complicated by an infective illness (Kirkeby 1972 d) . The changes that are known to occur in linoleic acid levels in thyrotoxicosis may be relevant to this study since it has been shown by Harvey (1971) (1972 c) suggests that the alteration in the fatty-acid pattern may result from the actions of increased free thyroxine, such as increased synthesis of saturated and monounsaturated fatty acids, increased mobilization of depot lipids rich in oleic but poor in linoleic acid, and increased utilization of existing linoleic acid. Valtnere (1959) has presented some evidence that thyroid function is increased in multiple sclerosis. In contrast, other values which may be increased in stress-noradrenaline and adrenocorticotrophin-have been shown to increase linoleic acid content of serum lipids (Jurand and Oliver, 1970 b, Kirkeby and Bjerkedal, 1972) . A decreased level of linoleic acid im serum lipids may be a general phenomenon of acute illness and the similarity of the pattern to that of essential fatty-acid deficiency may reflect a greater need of essential fatty acids in illness.
The reduction in linoleic acid levels was not peculiar to multiple sclerosis but was associated with diseases of varied aetiology. It would therefore seem that reduced levels were not specific to any illness. There was no evidence that lower linoleic acid levels altered the progress of any of the diseases included in this study. Furthermore, we have recently shown ) that lower serum linoleic acid levels persisted after clinical recovery in three cases of tetanus, three of viral meningitis, one of bacteraemia, one of cortical thrombophlebitis, and one of encephalitis. Though Millar et al. (1973) have shown in patients with multiple sclerosis that relapses were less frequent, and of shorter duration, after linoleic acid supplementation in the diet the overall rate of clinical derterioration was not altered. In view of the association of low linoleic acid levels with diseases other than multiple sclerosis we feel that the possible therapeutic benefit of dietary linoleic acid supplements in multiple sclerosis should be regarded with some reservation pending the results of further controlled studies.
